Join
today

Boliven PRO is more than just patent search

  • Build and save lists using the powerful Lists feature
  • Analyze and download your search results
  • Share patent search results with your clients

Patents »

WO200121201: USE OF REPLICATION-DEFICIENT ADENOVIRAL VECTOR TO BOOST CD8+ T CELL IMMUNE RESPONSE TO ANTIGEN

Share

Filing Information

Inventor(s) Joerg SCHNEIDER · GILBERT, Sarah, Catherine · HANNAN, Carolyn, Mary · HILL, Adrian, Vivian, Sinton ·
Assignee(s) ISIS INNOVATION LIMITED · Joerg SCHNEIDER · GILBERT, Sarah, Catherine · HANNAN, Carolyn, Mary · HILL, Adrian, Vivian, Sinton ·
Attorney/Agent(s) Sen M. WALTON ·
Application Number GB0003601
Filing date 09/20/2000
Publication date 03/29/2001
U.S. Classifications --
International Classifications 7A 61K 39/00  ·
Kind CodeA2
No Claims, 3 Drawings


Abstract

Use of a replication-deficient adenoviral vector encoding an antigen or a CD8+ T cell epitope of the antigen to boost in the individual a CD8+ T cell immune response to the antigen following prior administration of a priming composition. The priming composition comprises the antigen or epitope or nucleic acid encoding the antigen or epitope, and may be DNA, Ty-LVP'S or Modified Virus Ankara (MVA). Administration may be intradermal or intramuscular.

Independent Claims

The current document has no claims.

References Cited

The current document has no citations.

Patent Family

The current document is not in a family.